These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 18818704

  • 21. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
    Xu W, Li JY, Wu YJ, Yu H, Shen QD, Li L, Fan L, Qiu HX.
    Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
    [Abstract] [Full Text] [Related]

  • 22. Tumor Protein 53 Gene Mutations Without 17p13 Deletion Have No Significant Clinical Implications in Chronic Lymphocytic Leukemia. Detection of a New Mutation.
    Diamantopoulos PT, Samara S, Kollia P, Giannakopoulou N, Sofotasiou M, Kalala F, Kodandreopoulou E, Zervakis P, Vassilakopoulos T, Siakantaris M, Mantzourani M, Angelopoulou M, Kyrtshonis MC, Korkolopoulou P, Patsouris E, Viniou NA.
    Anticancer Res; 2017 May; 37(5):2387-2391. PubMed ID: 28476805
    [Abstract] [Full Text] [Related]

  • 23. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U, Dalla-Favera R.
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [Abstract] [Full Text] [Related]

  • 24. A new genetic abnormality leading to TP53 gene deletion in chronic lymphocytic leukaemia.
    López C, Baumann T, Costa D, López-Guerra M, Navarro A, Gómez C, Arias A, Muñoz C, Rozman M, Villamor N, Colomer D, Montserrat E, Campo E, Carrió A.
    Br J Haematol; 2012 Mar; 156(5):612-8. PubMed ID: 22150335
    [Abstract] [Full Text] [Related]

  • 25. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.
    Van Den Neste E, Robin V, Francart J, Hagemeijer A, Stul M, Vandenberghe P, Delannoy A, Sonet A, Deneys V, Costantini S, Ferrant A, Robert A, Michaux L.
    Leukemia; 2007 Aug; 21(8):1715-22. PubMed ID: 17541398
    [Abstract] [Full Text] [Related]

  • 26. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization to detect chromosomal abnormalities in chronic lymphocytic leukemia: a comparative study.
    Fabris S, Scarciolla O, Morabito F, Cifarelli RA, Dininno C, Cutrona G, Matis S, Recchia AG, Gentile M, Ciceri G, Ferrarini M, Ciancio A, Mannarella C, Neri A, Fragasso A.
    Genes Chromosomes Cancer; 2011 Sep; 50(9):726-34. PubMed ID: 21638517
    [Abstract] [Full Text] [Related]

  • 27. Unraveling the molecular pathogenesis of chronic lymphocytic leukemia: dissecting a microRNA regulatory network.
    Allendorf DJ, Davis RS.
    JAMA; 2011 Jan 05; 305(1):95-7. PubMed ID: 21205973
    [No Abstract] [Full Text] [Related]

  • 28. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Cavazzini F, Milani R, Minotto C, Tieghi A, Della Porta M, Agostini P, Tammiso E, Negrini M, Castoldi G.
    Haematologica; 2002 Jan 05; 87(1):44-51. PubMed ID: 11801464
    [Abstract] [Full Text] [Related]

  • 29. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
    Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R.
    Blood; 2010 May 27; 115(21):4191-7. PubMed ID: 20089965
    [Abstract] [Full Text] [Related]

  • 30. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E, Norberg M, Kanduri M, Tobin G, Säisänen L, Aberg M, Gustafsson MG, Sundström C, Rosenquist R, Aleskog A.
    Eur J Haematol; 2009 Jul 27; 83(1):22-34. PubMed ID: 19245531
    [Abstract] [Full Text] [Related]

  • 31. A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53.
    Shindiapina P, Brown JR, Danilov AV.
    Br J Haematol; 2014 Oct 27; 167(2):149-61. PubMed ID: 25040077
    [Abstract] [Full Text] [Related]

  • 32. Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia.
    Dickinson JD, Smith LM, Sanger WG, Zhou G, Townley P, Lynch JC, Pavletic ZS, Bierman PJ, Joshi SS.
    Br J Haematol; 2005 Feb 27; 128(4):460-71. PubMed ID: 15686453
    [Abstract] [Full Text] [Related]

  • 33. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S, López A, Rasillo A, Sayagués JM, Barrena S, Sánchez ML, Teodosio C, Giraldo P, Giralt M, Pérez MC, Romero M, Perdiguer L, Orfao A.
    Cytometry B Clin Cytom; 2008 May 27; 74(3):139-49. PubMed ID: 18061951
    [Abstract] [Full Text] [Related]

  • 34. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
    Kalla C, Scheuermann MO, Kube I, Schlotter M, Mertens D, Döhner H, Stilgenbauer S, Lichter P.
    Eur J Cancer; 2007 May 27; 43(8):1328-35. PubMed ID: 17449237
    [Abstract] [Full Text] [Related]

  • 35. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.
    Fenaux P, Preudhomme C, Laï JL, Quiquandon I, Jonveaux P, Vanrumbeke M, Sartiaux C, Morel P, Loucheux-Lefebvre MH, Bauters F.
    Leukemia; 1992 Apr 27; 6(4):246-50. PubMed ID: 1588788
    [Abstract] [Full Text] [Related]

  • 36. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
    Schetelig J, van Biezen A, Brand R, Caballero D, Martino R, Itala M, García-Marco JA, Volin L, Schmitz N, Schwerdtfeger R, Ganser A, Onida F, Mohr B, Stilgenbauer S, Bornhäuser M, de Witte T, Dreger P.
    J Clin Oncol; 2008 Nov 01; 26(31):5094-100. PubMed ID: 18711173
    [Abstract] [Full Text] [Related]

  • 37. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V.
    Clin Cancer Res; 2010 Jan 15; 16(2):620-8. PubMed ID: 20068100
    [Abstract] [Full Text] [Related]

  • 38. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC, GEIL.
    Haematologica; 2008 Feb 15; 93(2):215-23. PubMed ID: 18223290
    [Abstract] [Full Text] [Related]

  • 39. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
    Pekova S, Mazal O, Cmejla R, Hardekopf DW, Plachy R, Zejskova L, Haugvicova R, Jancuskova T, Karas M, Koza V, Smolej L, Bezdickova L, Kozak T.
    Leuk Res; 2011 Jul 15; 35(7):889-98. PubMed ID: 21232794
    [Abstract] [Full Text] [Related]

  • 40. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
    Sarsotti E, Marugan I, Benet I, Terol MJ, Sanchez-Izquierdo D, Tormo M, Rubio-Moscardo F, Martinez-Climent JA, García-Conde J.
    Leukemia; 2004 Apr 15; 18(4):743-6. PubMed ID: 14961033
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.